# EDGAR Filing Document

**Accession Number:** 0001879293
**File Stem:** 0001493152-23-007396
**Filing Date:** 2023-3
**Character Count:** 39377
**Document Hash:** 5929b2440a56f9515b37549dc157a8e1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-007396.hdr.sgml**: 20230313

**ACCESSION NUMBER**: 0001493152-23-007396

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 35

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230313

**DATE AS OF CHANGE**: 20230313

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Myson, Inc.
- **CENTRAL INDEX KEY:** 0001879293
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL PROCESS FURNACES & OVENS [3567]
- **IRS NUMBER:** 871614433
- **STATE OF INCORPORATION:** OK
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56333
- **FILM NUMBER:** 23727202

**BUSINESS ADDRESS:**
- **STREET 1:** 3625 COVE POINT DRIVE
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84109
- **BUSINESS PHONE:** 801 209 0740

**MAIL ADDRESS:**
- **STREET 1:** 3625 COVE POINT DRIVE
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84109

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-Q**

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended January 31, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

for the transition period from __________________ to __________________

Commission File Number 0-56333

**MYSON, INC.**

(Exact Name of registrant as specified in its charter)

<u>Oklahoma</u> <u>87-1614433</u> <br> (State or other Jurisdiction of I.R.S. Employer- <br> Incorporation or Organization Identification No.)

7950 W. Sunset Blvd., Ste 629 Los Angeles CA 90046

(Address of Principal Executive Offices and zip code)

(310) 666-0750

(Registrant's Telephone Number, including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock | MYSN |  |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13, or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (of for such shorter period that the Registrant was required to file such reports) and (ii) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act:

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

Indicate the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date.

As of March 3, 2023, there were 10,133,284 shares of Common Stock, $.00001 par value.

**MYSON, INC.**

**FORM 10-Q**

**For the Period ended <u>January 31, 2023</u>**

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
| [PART I – FINANCIAL INFORMATION](#a_001) | 3 |
| &nbsp;&nbsp;&nbsp;[Item 1. Financial Statements](#a_002) | 3 |
| &nbsp;&nbsp;&nbsp;[Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_003) | 10 |
| &nbsp;&nbsp;&nbsp;[Item 3. Quantitative and Qualitative Disclosures About Market Risk](#a_004) | 12 |
| &nbsp;&nbsp;&nbsp;[Item 4. Controls and Procedures](#a_005) | 12 |
| [PART II – OTHER INFORMATION](#a_006) | 13 |
| &nbsp;&nbsp;&nbsp;[Item 1. Legal Proceedings](#a_007) | 13 |
| &nbsp;&nbsp;&nbsp;[Item 1A. Risk Factors](#a_008) | 13 |
| &nbsp;&nbsp;&nbsp;[Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#a_009) | 13 |
| &nbsp;&nbsp;&nbsp;[Item 3. Defaults Upon Senior Securities](#a_010) | 13 |
| &nbsp;&nbsp;&nbsp;[Item 4. Mine Safety Disclosures](#a_011) | 13 |
| &nbsp;&nbsp;&nbsp;[Item 5. Other Information](#a_012) | 13 |
| &nbsp;&nbsp;&nbsp;[Item 6. Exhibits](#a_013) | 14 |
| [SIGNATURES](#a_014) | 15 |

---

**PART I – FINANCIAL INFORMATION**

**Item 1. Financial Statements**

---

| | |
|:---|:---|
| [Condensed Balance Sheets as of January 31, 2023 (unaudited) and July 31, 2022 (audited)](#a_015) | 4 |
| [Condensed Statements of Operations for the Three and Six Months ended January 31, 2023 and 2022 (unaudited)](#a_016) | 5 |
| [Condensed Statement of Changes in Stockholders' Deficit for the Three and Six Months ended January 31, 2023 and 2022 (unaudited)](#a_017) | 6 |
| [Condensed Statements of Cash Flows for the Six Months ended January 31, 2023 and 2022 (unaudited)](#a_018) | 7 |
| [Notes to Condensed Financial Statements (unaudited)](#a_019) | 8 |

---

**MYSON, INC.**

**CONDENSED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
|  | January 31, 2023 | July 31, 2022 |
|  | (Unaudited) | (Audited) |
| <u>ASSETS</u> |  |  |
| Current Assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash | $— | $— |
| Total Current Assets |  |  |
| Total Assets | $— | $— |
| <u>LIABILITIES AND STOCKHOLDERS' DEFICIT</u> |  |  |
| Current Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $350 | $282 |
| &nbsp;&nbsp;&nbsp;Loan payable – related party | 75047 | 37649 |
| Total Current Liabilities | 75397 | 37931 |
| Stockholders' Deficit: |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock, $0.00001 par value, 20,000,000 shares authorized |  |  |
| &nbsp;&nbsp;&nbsp;Series A Preferred stock, $0.00001 par value, 1,000,000 shares designated, 1,000 shares issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, $0.00001 par value, 480,000,000 shares authorized; 10,133,284 shares issued and outstanding | 101 | 101 |
| &nbsp;&nbsp;&nbsp;Additional paid in capital | 27639 | 27639 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (103137) | (65671) |
| Total stockholders' deficit | (75397) | (37931) |
| Total Liabilities and Stockholders' Deficit | $— | $— |

---

*The accompanying notes are an integral part of these unaudited condensed financial statements.*

**MYSON, INC.**

**CONDENSED STATEMENTS OF OPERATIONS**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | For the Three Months Ended<br> January 31, | For the Three Months Ended<br> January 31, | For the Six Months Ended<br> January 31, | For the Six Months Ended<br> January 31, |
|  | 2023 | 2022 | 2023 | 2022 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;General and administrative | $12662 | $4551 | $37466 | $24703 |
| Total operating expenses | 12662 | 4551 | 37466 | 24703 |
| Loss from operations | (12662) | (4551) | (37466) | (24703) |
| Net Loss | $(12662) | $(4551) | $(37466) | $(24703) |
| Loss per share, basic & diluted | $(0.00) | $(0.00) | $(0.00) | $(0.00) |
| Weighted average shares outstanding, basic & diluted | 10133284 | 10133284 | 10133284 | 10133284 |

---

*The accompanying notes are an integral part of these unaudited condensed financial statements.*

**MYSON, INC.**

**CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT**

**FOR THE THREE AND SIX MONTHS ENDED JANUARY 31, 2023 AND 2022**

**(Unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Common Stock | Common Stock | Series A<br> Preferred Stock | Series A<br> Preferred Stock | | | |
|  | Shares | Amount | Shares | Amount | Additional Paid in<br>Capital | Accumulated<br>Deficit | Total Stockholders'<br>Deficit |
| Balances, July 31, 2021 | 133284 | $1 | 1000 | $— | $100 | $(101) | $— |
| Contributions to capital |  | &nbsp;&nbsp;&nbsp;&nbsp;— |  | &nbsp;&nbsp;&nbsp;&nbsp;— | 19520 |  | 19520 |
| Net loss |  |  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;(20152) | &nbsp;&nbsp;&nbsp;&nbsp;(20152) |
| Balances, October 31, 2021 | 133284 | 1 | 1000 |  | 19620 | (20253) | (632) |
| Contributions to capital |  |  |  |  | 4901 |  | 4901 |
| Net loss |  |  |  |  |  | (4551) | (4551) |
| Balances, January 31, 2022 | 133284 | $1 | 1000 | $— | $24520 | $(24804) | $(282) |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Common Stock | Common Stock | Series A<br> Preferred Stock | Series A<br> Preferred Stock | | | |
|  | Shares | Amount | Shares | Amount | Additional Paid in<br>Capital | Accumulated<br>Deficit | Total Stockholders'<br>Deficit |
| Balances, July 31, 2022 | 10133284 | $101 |  | $— | $&nbsp;&nbsp;&nbsp;&nbsp;27639 | $(65671) | $&nbsp;&nbsp;&nbsp;&nbsp;(37931) |
| Net loss |  | &nbsp;&nbsp;&nbsp;&nbsp;— |  | &nbsp;&nbsp;&nbsp;&nbsp;— |  | (24804) | (24804) |
| Balances, October 31, 2022 | 10133284 | 101 |  |  | 27639 | (90475) | (62735) |
| Net loss |  |  |  |  |  | (12662) | (12662) |
| Balances, January 31, 2023 | 10133284 | $101 |  | $— | $27639 | $(103137) | $(75397) |

---

*The accompanying notes are an integral part of these unaudited condensed financial statements.*

**MYSON, INC.**

**CONDENSED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | For the Six Months Ended<br> January 31, | For the Six Months Ended<br> January 31, |
|  | 2023 | 2022 |
| Cash Flows from Operating Activities: |  |  |
| Net loss | $(37466) | $(24703) |
| Adjustments to reconcile net loss to net cash used in Operating activities: |  |  |
| Changes in Operating Assets and Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | 68 | 282 |
| Net cash used by operating activities | (37398) | (24421) |
| Cash Flows from Financing Activities: |  |  |
| &nbsp;&nbsp;&nbsp;Loan payable – related party |  |  |
| &nbsp;&nbsp;&nbsp;Contributions to capital by controlling shareholder | 37398 | 24421 |
| Net cash provided by financing activities | 37398 | 24421 |
| Net change in cash |  |  |
| Cash, at beginning of period |  |  |
| Cash, at end of period | $— | $— |
| Supplemental Non-Cash Disclosure: |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for interest | $— | $— |
| &nbsp;&nbsp;&nbsp;Cash paid for taxes | $— | $— |

---

*The accompanying notes are an integral part of these unaudited condensed financial statements.*

**MYSON, INC.**

**NOTES TO UNAUDITED FINANCIAL STATEMENTS**

**January 31, 2023**

**NOTE 1 – NATURE OF OPERATIONS**

Myson, Inc. ("Myson", or the "Company") is an Oklahoma corporation formed on July 8, 2021. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a "Business Combination"). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of January 31, 2023, the Company has not commenced any operations. All activity for the period from July 8, 2021 (inception) through January 31, 2023, relates to the Company's formation and the filing of its Registration Statement on Form 10, which was effective on October 23, 2021, and the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest.

On May 11, 2022, G. Reed Petersen Irrevocable Trust (the "Seller"), agreed to sell all 1,000 issued and outstanding Series A Preferred Shares of the Company to Reddington Partners LLC (the "Purchaser"), thus constituting a change of control of the Company, for $495,000, pursuant to a Stock Purchase Agreement (the "Stock Purchase Agreement"). The Preferred Shares were convertible into 10,000,000 common shares which, upon conversion, represent approximately 98.7% of the Company's outstanding common shares. On June 8, 2022, Reddington Partners LLC converted their Series A Preferred Shares into 10,000,000 common shares, and there are no Preferred Shares currently issued and outstanding.

The sale of the Shares to the Purchaser was completed on May 17, 2022. As part of the Stock Purchase Agreement, G. Reed Petersen agreed to resign as the Company's sole officer and director; and the change of management was completed on June 5, 2022. On June 6, 2022, Henrik Rouf became the Company's sole officer and director.

**NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

*<u>Basis of Presentation</u>*

 

The Company's unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). The accompanying unaudited condensed financial statements reflect all adjustments, consisting of only normal recurring items, which, in the opinion of management, are necessary for a fair statement of the results of operations for the periods shown and are not necessarily indicative of the results to be expected for the full year ending July 31, 2023. These unaudited condensed financial statements should be read in conjunction with the financial statements and related notes included in the Company's Annual Report on Form 10-K for the year ended July 31, 2022.

*<u>Use of estimates</u>*

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.

*<u>Cash and Cash Equivalents</u>*

 

The Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less as cash and cash equivalents. The carrying amount of financial instruments included in cash and cash equivalents approximates fair value because of the short maturities for the instruments held. The Company had no cash equivalents as of January 31, 2023 and July 31, 2022.

*<u>Basic and Diluted Earnings Per Share</u>*

Net income (loss) per common share is computed pursuant to ASC 260-10-45, *Earnings per Share—Overall—Other Presentation Matters*. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The Company has no potentially dilutive shares of common stock as of January 31, 2023 and July 31, 2022.

*<u>Recent Accounting Pronouncements</u>*

 

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

**NOTE 3 – GOING CONCERN**

These unaudited financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. At January 31, 2023, the Company has not yet achieved profitable operations, has accumulated losses of $103,137 since its inception, has no working capital, and expects to incur further losses in the development of its business, all of which raise substantial doubt about the Company's ability to continue as a going concern. The Company's ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has no formal plan in place to address this concern but considers that the Company will be able to obtain additional funds by equity financing and/or related party advances, however, there is no assurance of additional funding being available or on terms acceptable to the Company.

**NOTE 4 - RELATED PARTY TRANSACTIONS**

During the six months ended January 31, 2023, Reddington Partners LLC, the majority shareholder, advanced the Company $37,398 to pay for general operating expenses. As of January 31, 2023, the Company owes Reddington Partners LLC, a total of $75,046 for advances to the Company. The advances are non-interest bearing and due on demand.

**NOTE 5 – COMMON STOCK**

The Company has authorized 480,000,000 shares of common stock, par value $0.00001.

Effective February 24, 2022, the Company effectuated a 1 for 10,000 reverse stock split. All share numbers throughout these financial statements have been retroactively restated.

**NOTE 6 – PREFERRED STOCK**

The Company has authorized 20,000,000 shares of preferred stock, par value $0.00001. The Preferred Stock authorized by these Articles of Incorporation may be issued in one or more series. The Board of Directors of the Corporation is authorized to determine or alter the rights, preferences, privileges, and restrictions granted or imposed upon any wholly unissued series of Preferred Stock, and within the limitations or restrictions stated in any resolution or resolutions of the Board of Directors originally fixing the number of shares constituting any series, to increase or decrease (but not below the number of shares of any such series then outstanding) the number of shares of any such series subsequent to the issue of shares of that series, to determine the designation and par value of any series and to fix the numbers of shares of any series.

Of the authorized preferred stock 1,000 shares have been designated as Series A Convertible Preferred Stock. Each share of Series A Convertible Preferred Stock is convertible into 10,000 shares of common stock and has 100,000 voting rights per share.

On June 8, 2022, the Reddington Partners LLC converted the Series A Preferred Shares into 10,000,000 common shares.

**NOTE 7 - SUBSEQUENT EVENTS**

Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date the financial statements were issued and has determined that no material subsequent events exist.

**Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION**

The following discussion and analysis of the Company's financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

*Special Note Regarding Forward-Looking Statements*

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements." These forward-looking statements generally are identified by the words "believes," "project," "expects," "anticipates," "estimates," "intends," "strategy," "plan," "may," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.

***General Overview***

We were incorporated on July 8, 2021 as an Oklahoma corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. We intend to effectuate our initial business combination using our capital stock, debt or a combination of cash, stock and debt.

On May 11, 2022, G. Reed Petersen Irrevocable Trust (the "Seller"), agreed to sell all 1,000 issued and outstanding Series A Preferred Shares of the Company to Reddington Partners LLC (the "Purchaser"), thus constituting a change of control of the Company, for $495,000, pursuant to a Stock Purchase Agreement (the "Stock Purchase Agreement"). The Preferred Shares were convertible into 10,000,000 common shares which, upon conversion, represent approximately 98.7% of the Company's outstanding common shares.

The sale of the Shares to the Purchaser was completed on May 17, 2022. As part of the Stock Purchase Agreement, G. Reed Petersen agreed to resign as the Company's sole officer and director; and the change of management was completed on June 5, 2022. On June 6, 2022, Henrik Rouf became the Company's sole officer and director.

***Current Business***

We have neither engaged in any operations nor generated any operating revenues to date. We are currently a "shell," as that term is defined pursuant to Rule 12b-2 of the Securities Exchange Act of 1934. Our only activities for the period from July 8, 2021 (inception) through January 31, 2023 were organizational activities, preparing and filing a Form 10 with the SEC, and then identifying a target company for a business combination. We will not generate any operating revenues until after completion of our initial business combination. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

 ****

***Results of Operations***

**<u>Results of Operations for the Three Months Ended January 31, 2023 Compared to the Three Months Ended January 31, 2022</u>**

*<u>Revenue</u>*

We did not recognize any revenue for the three months ended January 31, 2023 and 2022.

*<u>General and administrative</u>*

General and administrative expense was $12,662 and $4,551 for the three months ended January 31, 2023 and 2022, respectively. Expenses were for accounting fees, transfer agent fees, edgarization fees and postage expenses, primarily related to the costs of maintaining our company current with the transfer agent and with our filing obligations with the Securities and Exchange Commission.

*<u>Net Loss</u>*

For the three months ended January 31, 2023, we had a net loss of $12,662 as compared to a net loss of $4,551 for the three months ended January 31, 2022.

**<u>Results of Operations for the Six Months Ended January 31, 2023 Compared to the Six Months Ended January 31, 2022</u>**

*<u>Revenue</u>*

We did not recognize any revenue for the six months ended January 31, 2023 and 2022.

*<u>General and administrative</u>*

General and administrative expense was $37,466 and $24,703 for the six months ended January 31, 2023 and 2022, respectively. Expenses were for accounting fees, transfer agent fees, edgarization fees and postage expenses, primarily related to the costs of maintaining our company current with the transfer agent and with our filing obligations with the Securities and Exchange Commission.

*<u>Net Loss</u>*

For the six months ended January 31, 2023, we had a net loss of $37,466 as compared to a net loss of $24,703 for the six months ended January 31, 2022.

***Liquidity and capital resources.***

The Company has no working capital, with all of its foreseeable capital needs being met by contributions or loans from its sole officer and director. The Company has no business at this time and is seeking to acquire another business.

***Cash flows***

*<u>Operating Activities</u>*

Cash used by operating activities was $37,398 for the six months ended January 31, 2023, compared to cash used for operating activities of $24,421 for the six months ended January 31, 2023.

*<u>Investing Activities</u>*

We used $0 for investing activities for the six months ended January 31, 2023 and 2022.

*<u>Financing Activities</u>*

Net cash provided by financing activities was $37,398 for six months ended January 31, 2023, compared to $24,421 for the six months ended January 31, 2022. During the current period we received $37,398 from the majority shareholder. During the prior period, we received $24,421 that was contributed by the former majority shareholder.

**Off-Balance Sheet Arrangements**

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

**Critical Accounting Policies**

Refer to Note 2 of our financial statements contained elsewhere in this Form 10-Q for a summary of our critical accounting policies and recently adopting and issued accounting standards.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.**

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.

**ITEM 4. CONTROLS AND PROCEDURES.**

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under Securities Exchange Act of 1934, as amended (the "Exchange Act") is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

*Evaluation of Disclosure Controls and Procedures*

We conducted an evaluation of the effectiveness of our internal control over financial reporting, based on the framework in "Internal Control Integrated Framework" issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO") and published in 2013, and subsequent guidance prepared by COSO specifically for smaller public companies. Based on that evaluation, management concluded that our internal control over financial reporting was not sufficient as of January 31, 2023.

A significant deficiency is a deficiency, or combination of deficiencies in internal control over financial reporting, that adversely affects the entity's ability to initiate, authorize, record, process, or report financial data reliably in accordance with generally accepted accounting principles such that there is more than a remote likelihood that a misstatement of the entity's financial statements that is more than inconsequential will not be prevented or detected by the entity's internal control. A material weakness is a deficiency or a combination of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. Management identified the following material weakness and significant deficiencies in its assessment of the effectiveness of internal control over financial reporting as of January 31, 2023:

● The Company did not maintain effective controls over certain aspects of the financial reporting process because we lacked personnel with accounting expertise and an adequate supervisory review structure that is commensurate with our financial reporting requirements.

● Material Weakness – Inadequate segregation of duties.

We expect to be materially dependent on a third party that can provide us with accounting consulting services for the foreseeable future. Until such time as we have a chief financial officer with the requisite expertise in U.S. GAAP, there are no assurances that the material weaknesses and significant deficiencies in our disclosure controls and procedures and internal control over financial reporting will not result in errors in our financial statements, which could lead to a restatement of those financial statements. Our management does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and maintained, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must account for resource constraints. In addition, the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, can and will be detected.

This Quarterly Report on Form 10-Q does not include an attestation report from our registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by the Company's registered public accounting firm pursuant to rules of the Commission that permit us to provide only management's report in this Quarterly Report on Form 10-Q.

*Changes in Internal Controls over Financial Reporting*

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

**PART II. OTHER INFORMATION**

**Item 1. Legal Proceedings**

We know of no material, existing or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our company.

**Item 1A. Risk Factors**

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceed**

None.

**Item 3. Defaults Upon Senior Securities**

None.

**Item 4. Mine Safety Disclosures**

Not applicable

**Item 5. Other Information**

None

**Item 6. Exhibits**

---

| | | |
|:---|:---|:---|
| Exhibit No. | Description | Note |
| 2.1 | [Agreement and Plan of Merger dated July 8, 2021](https://www.sec.gov/Archives/edgar/data/1879293/000187929321000001/ex21.htm) | (1) |
| 3.(i)1 | [Articles of Incorporation](https://www.sec.gov/Archives/edgar/data/1879293/000187929321000001/ex31.htm) | (1) |
| 3.(i)2 | [Bylaws](https://www.sec.gov/Archives/edgar/data/1879293/000187929321000001/ex32.htm) | (1) |
| 31 | [Certification of Chief Executive and Financial Officer (Rule 13a-14(a))](ex31-1.htm) | Filed herewith |
| 32 | [Certification of Chief Executive and Financial Officer (18 USC 1350)](ex32-1.htm) | Filed herewith |
| 101 INS | Inline XBRL Instance Document | Filed herewith |
| 101 SCH | Inline XBRL Taxonomy Extension Schema Document. | Filed herewith |
| 101 Cal | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | Filed herewith |
| 101 DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | Filed herewith |
| 101 LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | Filed herewith |
| 101 PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | Filed herewith |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | Filed herewith |

---

(1) Incorporated by reference to such exhibit as filed with the Company's Registration Statement on Form 10 filed on August 23, 2021.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| MYSON, INC. | MYSON, INC. |
| Date: March 13, 2023 | Date: March 13, 2023 |
| *By* | */s/ Henrik Rouf* |
|  | Henrik Rouf |
|  | Chief Executive Officer and Chief Financial Officer |

---

## Exhibit 31.1

**Exhibit 31.1**

**<u>Certification of Chief Executive Officer and Chief Financial Officer and Pursuant to</u>**

**<u>Section 302 of the Sarbanes-Oxley Act of 2002-Rule 13a-14(a)/15d –14(a)</u>**

I, Henrik Rouf, certify that:

1. I have reviewed this report on Form 10-Q of Myson, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

a. Designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to
 ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
 within those entities, particularly during the period in which this report is being prepared;

b. Designed
 such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my
 supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
 for external purposes in accordance with generally accepted accounting principles;

c. Evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
 the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
 and

d. Disclosed
 in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
 most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
 or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All
 significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
 reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
 and

b. Any
 fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
 internal control over financial reporting.

---

| | | |
|:---|:---|:---|
|  | Myson, Inc. | Myson, Inc. |
| Date: March 13, 2023 | By | */s/ Henrik Rouf* |
|  |  | Henrik Rouf, |
|  |  | Chief Executive Officer and |
|  |  | Chief Financial Officer |
|  |  | (Principal Executive and Financial Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO<br> 18 U.S.C. SECTION 1350,<br> AS ADOPTED PURSUANT TO<br> SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Myson, Inc., (the "Company") on Form 10-Q for the fiscal quarter ended January 31, 2023, as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), I, Henrik Rouf, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
|  | Myson, Inc. | Myson, Inc. |
| Date: March 13, 2023 | By | */s/ Henrik Rouf* |
|  |  | Henrik Rouf |

---